These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8154937)

  • 1. HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus.
    Davies EJ; Hutchings CJ; Hillarby MC; Donn RP; Cooper RG; Hay EM; Bernstein RM; Holt PJ; Grennan DM; Ollier WE
    Ann Rheum Dis; 1994 Mar; 53(3):188-90. PubMed ID: 8154937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production.
    Martín-Villa JM; Martínez-Laso J; Moreno-Pelayo MA; Castro-Panete MJ; Martínez-Quiles N; Alvarez M; de Juan MD; Gómez-Reino JJ; Arnaiz-Villena A
    Ann Rheum Dis; 1998 Apr; 57(4):214-9. PubMed ID: 9709177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA typing for HLA-DPB1-alleles in German patients with systemic lupus erythematosus using the polymerase chain reaction and DIG-ddUTP-labelled oligonucleotide probes. Members of SLE Study Group.
    Yao Z; Hartung K; Deicher HG; Brünnler G; Bettinotti MP; Keller E; Paul C; Gawron C; Mikschl S; Albert E
    Eur J Immunogenet; 1993 Aug; 20(4):259-66. PubMed ID: 8399121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets.
    Galeazzi M; Sebastiani GD; Passiu G; Angelini G; Delfino L; Asherson RA; Khamashta MA; Hughes GR
    J Rheumatol; 1992 Jan; 19(1):42-6. PubMed ID: 1556698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of the HLA class II antigens with clinical and autoantibody expression in Malaysian Chinese patients with systemic lupus erythematosus.
    Azizah MR; Ainoi SS; Kuak SH; Kong NC; Normaznah Y; Rahim MN
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):93-100. PubMed ID: 11699726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE-Studie.
    Hartung K; Coldewey R; Krapf F; Lang B; Specker C; Schendel D; Schneider P; Seuchter S; Stangel W; Albert E
    Tissue Antigens; 1991 Oct; 38(4):165-8. PubMed ID: 1801306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus.
    Davies EJ; Donn RP; Hillarby MC; Grennan DM; Ollier WE
    Ann Rheum Dis; 1994 Jan; 53(1):61-3. PubMed ID: 8311559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of established and novel alleles of the HLA-DPB1 locus by PCR-SSO.
    Pickl WF; Faé I; Fischer GF
    Vox Sang; 1993; 65(4):316-9. PubMed ID: 8310684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland.
    Steinsson K; Jónsdóttir S; Arason GJ; Kristjánsdóttir H; Fossdal R; Skaftadóttir I; Arnason A
    Ann Rheum Dis; 1998 Aug; 57(8):503-5. PubMed ID: 9797559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles.
    Spurkland A; Sollid LM; Rønningen KS; Bosnes V; Ek J; Vartdal F; Thorsby E
    Hum Immunol; 1990 Nov; 29(3):157-65. PubMed ID: 1980918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.
    Kagnoff MF; Harwood JI; Bugawan TL; Erlich HA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6274-8. PubMed ID: 2788285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus.
    Reveille JD; Anderson KL; Schrohenloher RE; Acton RT; Barger BO
    J Rheumatol; 1991 Jan; 18(1):14-8. PubMed ID: 1673720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles.
    Balducci-Silano PL; Layrisse ZE
    J Autoimmun; 1995 Jun; 8(3):425-37. PubMed ID: 7576003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus.
    Reveille JD; Moulds JM; Arnett FC
    Tissue Antigens; 1995 Feb; 45(2):91-7. PubMed ID: 7792766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.
    Stephens HA; McHugh NJ; Maddison PJ; Isenberg DA; Welsh KI; Panayi GS
    Immunogenetics; 1991; 33(4):276-80. PubMed ID: 1902824
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance.
    Reveille JD; Brady J; MacLeod-St Clair M; Durban E
    Tissue Antigens; 1992 Jul; 40(1):45-8. PubMed ID: 1440561
    [No Abstract]   [Full Text] [Related]  

  • 18. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population.
    Alvarado-Guerri R; Cabrera CM; Garrido F; López-Nevot MA
    Hum Immunol; 2005 Aug; 66(8):921-30. PubMed ID: 16216677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymorphism of HLA class II genes in systemic lupus erythematosus.
    Cowland JB; Andersen V; Halberg P; Morling N
    Tissue Antigens; 1994 Jan; 43(1):34-7. PubMed ID: 7912858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus.
    Tjernström F; Hellmer G; Nived O; Truedsson L; Sturfelt G
    Lupus; 1999; 8(2):103-8. PubMed ID: 10192503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.